Versant, Roche, Inception Sciences deal

Roche partnered with Versant and drug discovery company Inception Sciences to launch newco Inception 5 to screen and develop small molecules for myelin repair in multiple sclerosis (MS). Inception 5 has rights to a remyelination screening technology from the University of California, San Francisco. Versant will make an equity investment in Inception 5, and Roche will provide milestone-based research funding to the newco. Roche has an exclusive option to acquire Inception 5 upon filing of its first IND. ...